Your browser doesn't support javascript.
loading
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.
Gollins, Simon; West, Nicholas; Sebag-Montefiore, David; Susnerwala, Shabbir; Falk, Stephen; Brown, Nick; Saunders, Mark; Quirke, Philip; Ray, Ruby; Parsons, Philip; Griffiths, Gareth; Maughan, Tim; Adams, Richard; Hurt, Chris.
Afiliação
  • Gollins S; North Wales Cancer Treatment Centre, Bodelwyddan, Denbighshire, LL18 5UJ, UK. simon.gollins@wales.nhs.uk.
  • West N; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Sebag-Montefiore D; Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Cancer Centre, Leeds, LS9 7TF, UK.
  • Susnerwala S; Royal Preston Hospital, Fulwood, Preston, PR2 9HT, UK.
  • Falk S; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8ED, UK.
  • Brown N; Calderdale Royal Hospital, Salterhebble, Halifax, HX3 0PW, UK.
  • Saunders M; The Christie NHS Foundation Trust, Withington, Manchester, M20 4BX, UK.
  • Quirke P; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Ray R; Centre for Trials Research, Cardiff University, Room 409, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
  • Parsons P; NCRI RTTQA, Velindre Cancer Centre, Velindre NHS Trust, Velindre Road, Cardiff, CF14 2TL, UK.
  • Griffiths G; Southampton Clinical Trials Unit, Faculty of Medicine, Univeristy of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
  • Maughan T; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
  • Adams R; Centre for Trials Research, Cardiff University, Room 409, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
  • Hurt C; Centre for Trials Research, Cardiff University, Room 409, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Br J Cancer ; 119(6): 697-706, 2018 09.
Article em En | MEDLINE | ID: mdl-30116024
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante / Fluoruracila / Oxaliplatina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante / Fluoruracila / Oxaliplatina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido